- CUSIP
- 653942102
- Sector
- Healthcare
- Industry
- Biotechnology
Highlights
- EPS (TTM)
- -$3.13
- EBITDA (TTM)
- -$1.54M
- Year Range
- $6.00 - $12.24
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
NIKI Performance Chart
Loading charts...
Returns By Period
Niki BioSolutions, Inc.
- 1D
- 8.04%
- 1M
- —
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.89%
- 1M
- 0.11%
- 6M
- 10.48%
- YTD
- 9.70%
- 1Y
- 19.09%
- 3Y*
- 18.29%
- 5Y*
- 11.45%
- 10Y*
- 13.19%
- ALL TIME*
- 8.09%
NIKI Monthly Returns History
Based on dividend-adjusted daily data since Jul 17, 2026, NIKI's average daily return is +11.35%, while the average monthly return is +36.09%. At this rate, an investment would double in approximately 0.2 years.
Historically, 100% of months were positive and 0% were negative. The best month was Jul 2026 with a return of +36.1%, while the worst month was Jul 2026 at 36.1%. The longest winning streak lasted 1 consecutive months, and the longest losing streak was 0 months.
On a daily basis, NIKI closed higher 67% of trading days. The best single day was Jul 20, 2026 with a return of +26.1%, while the worst single day was Jul 17, 2026 at -0.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 36.09% | 36.09% |
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Niki BioSolutions, Inc. (NIKI) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NIKI | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.27 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.11 | — |
| Martin ratioReturn relative to average drawdown | — | 9.09 | — |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Niki BioSolutions, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Niki BioSolutions, Inc. was 0.14%, occurring on Jul 17, 2026. Recovery took 1 trading session.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-0.14%Jul 2026 | 0s | 3d | 3dJul 2026 - Jul 2026 | — |
Drawdown Indicators
| NIKI | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -0.14% | -56.78% | +56.64% |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | 0.00% | -1.32% | +1.32% |
Average DrawdownAverage peak-to-trough decline | -0.05% | -10.70% | +10.65% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.10% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Niki BioSolutions, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Niki BioSolutions, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with NIKI
Add Niki BioSolutions, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with NIKI